Clinical Trials Browser

Completed × INDUSTRY × AFM13 × Clear all

NCT04101331 2024-11-05

REDIRECT

Phase 2 Completed

108 enrolled 24 charts

Lymphoma, T-Cell, Peripheral

NCT02665650 2019-05-16

Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Phase 1 Completed

Hodgkin Disease